Sign up free to see prices on this bond
Free accounts get 40 bond price views per month — 4× the anonymous quota. Pro is unlimited.
About this bond
AI BRIEF · GROUNDED IN STRUCTURED DATAAlnylam Pharmaceuticals, Inc. is an American biopharmaceutical company focused on the discovery, development and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases. The company was founded in 2002 and is headquartered in Cambridge, Massachusetts. In 2016, Forbes included the company on its "100 Most Innovative Growth Companies" list.
Source: Wikipedia →Risk analytics
SEMI-ANNUAL · BULLET · PAR 100Price history
Sherpa Signal
AS OF 2026-05-01Institutional footprint · signal-level holdings
Sherpa Signal is derived from a panel of tracked institutional portfolios. Names of individual holders are not disclosed.
RFQ routing · coming soon
Security details
VIA OPENFIGIBonds like this
HEURISTICSame currency & sector, maturity within 7 years. Ranked by overlapping institutional owners, issuer match, and rating distance.